Abstract 2066P
Background
This study aimed to assess the usefulness of ChatGPT and Perplexity's responses to frequently asked questions regarding the diagnosis and treatment of rectal cancer.
Methods
Both artificial intelligence systems were asked 20 questions covering disease risk factors, screening, symptoms, treatment, and treatment side effects. In accordance with the ESMO patient guides, the questions were posed in the order specified. According to ESMO patient guide recommendations, responses were graded as “appropriate,” “inappropriate,” or “insufficient.”
Results
While ChatGPT provided appropriate responses to 17 of the questions (85%), the responses to two questions (10%) were deemed inappropriate, and the response to one question (5%) was deemed insufficient. Nineteen (95%) of Perplexity's responses were deemed appropriate. It was determined that both artificial intelligence systems responded improperly to the nutrition question.
Conclusions
The study's findings indicate that ChatGPT and Perplexity provide patients with accurate information about rectal cancer. The accuracy rate of Perplexity was found to be higher than that of ChatGPT. It can be demonstrated that the benefit of Perplexity is that it displays the source for each piece of information. However, especially cancer patients require emotional and psychological assistance, and further research is required to determine the impact of these artificial intelligence systems on the patient's psychology. Moreover, given the complexity and individuality of medical care, AI chatbots should not be viewed as a replacement for medical professionals, but rather as a supplement that can help patients gain access to trustworthy information and support. Overall, this study contributes to the growing body of literature on AI chatbots and their potential use in cancer by highlighting both the advantages and disadvantages of these technologies.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2055P - Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU
Presenter: Francisco Javier Ros Montana
Session: Poster session 06
2056P - Hospitalization, reconsultations and mortality in the field of oncological emergencies: Who is at higher risk?
Presenter: Eugenia María Martínez Madrid
Session: Poster session 06
2057P - Prevalence of frailty in long-term prostate cancer survivors after radical prostatectomy and its association with quality of life and emotional health
Presenter: Valentin Meissner
Session: Poster session 06
2058P - Reducing waste to improve sustainability and affordability of cancer treatment: Redispensing unused oral anticancer drugs
Presenter: Lisa-Marie Smale
Session: Poster session 06
2059P - The impact of a dental oncology clinic for patients (pts) prescribed bone-modifying agents (BMA) in a cancer centre
Presenter: Harriet Byrne
Session: Poster session 06
2060P - Prevalence and predictor of poor mental adjustment to cancer before lung cancer surgery
Presenter: Junhee Park
Session: Poster session 06
2061P - Network analysis of comprehensive concerns in patients with cancer: Differences between the sexes
Presenter: Kazumasa Yamamoto
Session: Poster session 06
2062P - The psychological distress (PsyD) evaluation in pancreatic cancer (PC) patients (pts): A mono-institutional analysis
Presenter: Maria Bensi
Session: Poster session 06
2063P - Lifestyle changes as cancer treatment: It is time to get specific with our patients
Presenter: Ana Isabel Martin Quesada
Session: Poster session 06
2064P - Hospitalisation of patients with cancer: Identifying points for improvement in patient care in a university hospital in Spain
Presenter: Silvia Roa
Session: Poster session 06